Tunable endogenous protein degradation with heterobifunctional compounds
US-12023385-B2 · Jul 2, 2024 · US
This page is not indexed by search engines while we improve data quality.
Winter Georg patents
Winter Georg is listed as an inventor on 25 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Winter Georg |
| Total patents | 25 |
| First publication | Jun 21, 2018 |
| Latest publication | Jul 2, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
US-2023131952-A1 · Apr 27, 2023 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-11583586-B2 · Feb 21, 2023 · US
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
US-11578075-B2 · Feb 14, 2023 · US
Tunable endogenous protein degradation
US-2022135967-A1 · May 5, 2022 · US
Regulating chimeric antigen receptors
US-11311609-B2 · Apr 26, 2022 · US
Tunable endogenous protein degradation
US-11293023-B2 · Apr 5, 2022 · US
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
US-2021301286-A1 · Sep 30, 2021 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-11059801-B2 · Jul 13, 2021 · US
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
US-11046954-B2 · Jun 29, 2021 · US
Recent patents
Latest publications not already listed above.
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
US-2021061811-A1 · Mar 4, 2021 · US
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
US-10925868-B2 · Feb 23, 2021 · US
Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use
US-10899768-B2 · Jan 26, 2021 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-2021015929-A1 · Jan 21, 2021 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-10849980-B2 · Dec 1, 2020 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-2020317635-A1 · Oct 8, 2020 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-10669253-B2 · Jun 2, 2020 · US
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
US-2019374528-A1 · Dec 12, 2019 · US
Tunable endogenous protein degradation with heterobifunctional compounds
US-2019374657-A1 · Dec 12, 2019 · US
Regulating chimeric antigen receptors
US-2019365875-A1 · Dec 5, 2019 · US
Degradation of protein kinases by conjugation of protein kinase inhibitors with e3 ligase ligand and methods of use
US-2019263823-A1 · Aug 29, 2019 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-2019151457-A1 · May 23, 2019 · US
Methods to induce targeted protein degradation through bifunctional molecules
US-2019071415-A1 · Mar 7, 2019 · US
Tunable endogenous protein degradation
US-2018179522-A1 · Jun 28, 2018 · US
Targeted protein degradation to attenuate adoptive t-cell therapy associated adverse inflammatory responses
US-2018169109-A1 · Jun 21, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Dana Farber Cancer Inst Inc | 25 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D487/04 | 17 |
| A61P35/00 | 17 |
| C07D401/14 | 15 |
| C07D471/04 | 13 |
| C07D495/04 | 11 |